Is Methylene Blue Safe Long-Term? What Research Suggests (2026)
Most methylene blue safety data comes from short-term clinical use, primarily for methemoglobinemia treatment, and does not directly address what […]
Methylene Blue for Women Over 40: Benefits and Considerations (2026)
Women over 40 exploring methylene blue are often approaching it from a cognitive-support or energy angle, sometimes alongside broader interest
Methylene Blue and Magnesium: A Complementary Stack? (2026)
Magnesium is one of the most commonly stacked supplements in nootropic and longevity communities, and methylene blue users frequently ask
Bioavailability of Methylene Blue: How to Maximize Absorption (2026)
Bioavailability, the proportion of a dose that reaches systemic circulation in an active form, is a meaningful practical consideration for
Methylene Blue Dosage for Beginners: Starting Low and Adjusting (2026)
Dosage is the single most important practical question for anyone new to methylene blue, precisely because this is a compound
Methylene Blue vs Placebo: What Controlled Trials Show (2026)
Placebo-controlled trials are the gold standard for separating a compound’s real effects from expectation, natural variation, and the attention that
Methylene Blue vs. Modafinil: Two Cognitive Enhancers With Very Different Mechanisms and Risk Profiles
Methylene Blue and Modafinil both attract nootropic interest, but their mechanisms, safety profiles, and evidence bases differ sharply. Here’s an honest compari
What Is Methylene Blue? A Science-First Introduction to an Old Drug With New Attention
Methylene blue: a century-old drug, FDA-approved in 2016, now studied as a nootropic. Its mechanisms, safety limits, and what science shows.
Methylene Blue vs. Rapamycin: Two Longevity Compounds, Two Very Different Mechanisms
Methylene Blue and Rapamycin target aging through distinct pathways. Here’s an honest, mechanism-focused comparison of what the science currently suggests.
Methylene Blue and Serotonin Syndrome: The SSRI, SNRI, and MAOI Interaction Explained
Methylene blue is a potent MAO inhibitor. Combined with SSRIs, SNRIs, or MAOIs it can trigger life-threatening serotonin syndrome. Here is what you need to know
Methylene Blue as a Nootropic: What the Research Actually Shows (And What It Doesn’t)
Methylene Blue is gaining nootropic attention for proposed mitochondrial and cognitive benefits. Here’s an honest look at the science, the gaps, and the real ri
Methylene Blue and Medical Supervision: Safety Protocols, Drug Interactions, and Who Should Avoid It
Methylene blue carries serious drug interaction risks and absolute contraindications. Learn why medical supervision is essential before using it.